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Introduction: Fe3O4 nanoparticles (Fe3O4 NPs) with multiple functionalities are intriguing 
candidates for various biomedical applications.
Materials and Methods: This study introduced a simple and green synthesis of Fe3O4 NPs 
using a low-cost stabilizer of plant waste extract rich in polyphenols content with a well-known 
antioxidant property as well as anticancer ability to eliminate colon cancer cells. Herein, Fe3O4 NPs 
were fabricated via a facile co-precipitation method using the crude extract of Garcinia mangostana 
fruit peel as a green stabilizer at different weight percentages (1, 2, 5, and 10 wt.%). The samples 
were analyzed for magnetic hyperthermia and then in vitro cytotoxicity assay was performed.
Results: The XRD planes of the samples were corresponding to the standard magnetite Fe3O4 
with high crystallinity. From TEM analysis, the green synthesized NPs were spherical with an 
average size of 13.42±1.58 nm and displayed diffraction rings of the Fe3O4 phase, which was in 
good agreement with the obtained XRD results. FESEM images showed that the extract covered 
the surface of the Fe3O4 NPs well. The magnetization values for the magnetite samples were 
ranging from 49.80 emu/g to 69.42 emu/g. FTIR analysis verified the functional groups of the 
extract compounds and their interactions with the NPs. Based on DLS results, the hydrodynamic 
sizes of the Fe3O4 nanofluids were below 177 nm. Furthermore, the nanofluids indicated the zeta 
potential values up to −34.92±1.26 mV and remained stable during four weeks of storage, 
showing that the extract favorably improved the colloidal stability of the Fe3O4 NPs. In the 
hyperthermia experiment, the magnetic nanofluids showed the acceptable specific absorption 
rate (SAR) values and thermosensitive performances under exposure of various alternating 
magnetic fields. From results of in vitro cytotoxicity assay, the killing effects of the synthesized 
samples against HCT116 colon cancer cells were mostly higher compared to those against 
CCD112 colon normal cells. Remarkably, the Fe3O4 NPs containing 10 wt.% of the extract 
showed a lower IC50 value (99.80 µg/mL) in HCT116 colon cancer cell line than in CCD112 
colon normal cell line (140.80 µg/mL).
Discussion: This research, therefore, introduced a new stabilizer of Garcinia mangostana 
fruit peel extract for the biosynthesis of Fe3O4 NPs with desirable physiochemical properties 
for potential magnetic hyperthermia and colon cancer treatment.
Keywords: green synthesis, Fe3O4 nanoparticles, Garcinia mangostana, magnetic 
hyperthermia, cytotoxicity assay
Introduction
Fe3O4 nanoparticles (Fe3O4 NPs) can play an important role in cancer therapy. 
Fabrication of Fe3O4 NPs can be carried out by different procedures such as co- 
precipitation, thermal decomposition, and green synthesis.1–3 Co-precipitation is 
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a conventional method withthe capability to produce large- 
scale of Fe3O4 NPs.4–6 This method still requires improve-
ment particularly in controlling the particle size and compo-
sition of the NPs. In synthesis of Fe3O4 NPs, different types 
of natural stabilizers such as plant extracts and bioactive 
molecules can increase the colloidal stability and physio-
chemical characteristic of Fe3O4 NPs.1,7–9 It has been 
reported that coating the NPs could be costly, laborious, 
time-consuming, and toxic to the environment when chemi-
cals are used.10 To overcome these issues, preparation of NPs 
by a green approach has drawn considerable attention.11 
During the green synthesis process, natural-based stabilizers 
may hydrolyze iron salt solution for ferric hydroxide forma-
tion, which is then reduced by biomolecules to form NPs.12 
As a green stabilizer, plant extracts and its polyphenolic 
compounds could be presented into/onto NPs to decrease 
particle interactions as well as improve thermodynamic 
stability.1,13 Therefore, Fe3O4 NPs stabilized with the plant 
extracts could potentially show better water permeability, 
antioxidant activity, biocompatibility, biodegradability, and 
tolerable toxicity for various biomedical applications com-
pared to using other traditional methods.14–16
Compared to the normal amount consumed with a low 
phenolic content, the plant extract might induce a greater 
amount of a metabolite compound of polyphenol or flavo-
noid subclass and distribute at the targeted site for stronger 
antioxidant and anticancer activities.17 Polyphenols, espe-
cially anthocyanins, undergo a major structural changes dur-
ing the in vitro or in vivo evaluations, improving both 
bioavailability and biological properties.18 It is worth men-
tioning that the peel of some fruits has higher antioxidant 
activities than the pulp.19 The extract of fruit peels such as 
Garcinia mangostana (G. mangostana)19 and mango20 are 
rich sources of antioxidants. Even though there are many 
studies related to the green synthesis of Fe3O4 NPs using 
different plant extracts such as Kappaphycus alvarezii21 and 
Punica granatum peel;6 however, applications of the green 
synthesized Fe3O4 NPs with anticancer properties are still 
less focused.1
Over the years, using agro-waste has been intriguing for 
researchers to fabricate environmental-friendly materials to 
tackle problems of toxicity and the reduction in landfill 
space.22 G. mangostana is known as mangosteen and con-
sidered as a tropical fruit from Guttiferea family. It contains 
17% outer pericarp, 48% inner pericarp, 31% juicy flesh, and 
4% cap.23 The pulp extract of G. mangostana has been 
famously used for a food supplement and herbal 
medicine.19 Peel of G. mangostana is considered as a waste 
material, albeit, its crude extract may contain benzophe-
nones, flavonoids, and anthocyanins compounds with anti-
oxidant properties.24 For example, xanthones in flavonoid 
compounds with a high composition of α-mangostin and γ- 
mangostin have been reported for anticancer treatments.24 
Xanthones have been used to treat different types of cancer 
cells.25 Despite that there have been some studies on 
G. mangostana fruit peels in synthesis of Au NPs26 and Ag 
NPs,27 there have been no precise studies on the ability of 
G. mangostana to synthesize Fe3O4 NPs.
Magnetic hyperthermia therapy (MHT) is currently con-
sidered as an attractive application of Fe3O4 NPs in cancer 
treatment, however, it is still under the clinical trial.28 For 
this purpose, the ferrofluid samples are exposed to an exter-
nal alternating magnetic field (AMF) in order to assess their 
heating capabilities known as specific absorption rate 
(SAR). In MHT, the AMF strengths can control the 
hyperthermia temperature (TH) and properties of Fe3O4 
NPs.29 It has been stated that a secure TH is ranged from 
42°C to 47°C to cause hydrolyzing the tissue’s proteins and 
acute necrotic cancer cell death over 30–60 min, whereas 
the normal cells can be unaffected due to heat transfer 
phenomena.28,30 It is worth mentioning that Fe3O4 NPs in 
a low-viscous medium may trigger a magnetic response of 
anisotropic particles to be physically rotated by Brownian 
heating loss mechanism for increments of TH and SAR 
values.31 This may be achieved by developing the green 
synthesis of Fe3O4 NPs stabilized with a plant extract.
Based on World Health Organization (WHO) report, 
there have been approximately 18 million cancer cases and 
nearly 9.6 million people have died of cancer in the year 
2018 alone.32 In nanomedicine, NPs smaller than 10 nm 
are likely to be removed through renal clearance, whereas 
NPs bigger than 100 nm can be trapped rapidly in spleen 
and liver via macrophage phagocytosis.33 Fe3O4 NPs with 
an appropriate size and surface chemistry can be applied 
for various therapeutic applications, including drug deliv-
ery, magnetic resonance imaging (MRI) contrast agent and 
MHT.1,34–37 There have been studies using co-precipita-
tion method to synthesize Fe3O4 NPs for colon cancer 
treatment.6,11,16,21 For instance, dextran-coated Fe3O4 
NPs were synthesized by using a facile co-precipitation 
method with a mean size of ~10 nm.38
To our best knowledge, this current study is probably the 
first report to use the crude extract of G. mangostana fruit 
peel as a novel and green stabilizer in the biosynthesis of 
Fe3O4 nanofluids with high quality and low-cost for potential 
hyperthermia and colon cancer treatments. The Fe3O4 NPs 
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samples were stabilized with various weight percentages of 
the peel extract and they were evaluated by X-ray powder 
diffraction (XRD), transmission electron microscopy (TEM), 
field emission electron microscope (FESEM), energy-disper-
sive X-ray spectroscopy (EDS), vibrating sample 
magnetometer (VSM), and Fourier-transform infrared spec-
troscopy (FTIR). Dynamic light scattering (DLS) was also 
used to examine the stability of the samples solutions over 
four weeks of storage. The green synthesized Fe3O4 NPs 
were assessed by magnetic hyperthermia analysis. In addi-
tion, the in vitro cytotoxicity assays of the samples were 
evaluated using the human colon cancer cell line (HCT116) 
and colon normal cell line (CCD112).
Materials and Methods
Materials
G. mangostana fruit was obtained from Terengganu, 
Malaysia. Iron (II) chloride tetrahydrate (FeCl2.4H2O 
≥ 99%) and iron (III) chloride hexahydrate (FeCl3. 
6H2O, 97%) were purchased from Sigma-Aldrich. 
Sodium hydroxide (NaOH) was purchased from R&M 
Chemicals. All aqueous solutions were prepared using 
double distilled water. The chemicals were used without 
further purification. All glassware used was washed with 
distilled water and dried before used.
Preparation of Garcinia mangostana Fruit 
Peel Extract
The extract of G. mangostana fruit peel was obtained using 
a modified method from our group.6,26 Briefly, the fruit peels 
were washed several times to remove dust, followed by 
drying at an ambient condition. A total of 10 g of the fruit 
peel was ground and mixed with 100 mL double deionized 
water at 80°C, using an oil bath under a constant stirring at 
250 rpm for 1 h. The crude extract solution (10 m/V) was 
filtered with filter paper (Fioroni 601) and oven-dried at 45°C 
for 24 h. The dried extract powder was termed as S5 and 
stored at 4°C for further processing.
Green Synthesis of Fe3O4 NPs Stabilized 
by the Extract of Garcinia mangostana 
Fruit Peel
A simple co-precipitation method and the extract of 
G. mangostana fruit peel as a novel stabilizing and capping 
agent were used to synthesize Fe3O4 NPs. The crude extract 
of G. mangostana fruit peel, iron salts, and sodium hydroxide 
acted as a stabilizer, iron sources, and a reducing agent, 
respectively.6 Four different extract solutions (wt.%) were 
prepared. In total, 1, 2, 5, and 10 g of the dried extract powder 
were added into four different beakers containing respec-
tively 99, 98, 95, and 90 g of double deionized water and 
stirred for 15 min at room temperature. FeCl3. 6H2O, 97% 
(2.53 g) and FeCl2.4H2O ≥ 99% (0.99 g) at a molar ratio of 
2:1 were respectively added into each solution. After that, 
NaOH (1 M) was dropwise added into the respective solu-
tions to adjust the pH to ~11 followed by vigorous stirring for 
another 30 min. Finally, the samples were centrifuged three 
times at 14,000 rpm for 12 min and the collected precipitates 
were oven-dried at 70°C. The same procedure without using 
the extract was carried out for the preparation of bare Fe3O4 
NPs. The synthesized Fe3O4 NPs with 0, 1, 2, 5, and 10 wt.% 
concentrations of the peel extract were termed as S0, S1, S2, 
S3, and S4, respectively, and the peel extract powder alone 
was termed as S5.
Characterization
The structural characteristics of the synthesized samples (~3 g) 
were analyzed by using a PANalytical X’Pert PRO XRD with 
Cu Kα radiation (λ= 0.15406nm). An applied current of 20 
mA and an accelerating voltage of 45 kV in a 2θ (from 5° to 
80°) with a scanning rate of 2θ/min were used. TEM (JEM- 
2100F-Japan) determined morphology, particle size, and struc-
ture of the sample as the solution of the sample (~1.5 mg in 
10 mL distilled water) was dropped onto 300-mesh copper 
grids and also a TEM image was analyzed under the micro-
scope. FESEM was used to determine the size distribution and 
morphology of the samples (~2 mg) by using a JSM-7800F 
Prime Schottky, then the FESEM attached to EDS analysis for 
chemical characterization of the samples. An accelerating 
voltage of the microscope was set at 5.0 kV and the standard 
magnification was selected at 40 kX. Moreover, VSM (Model 
7400, Tokyo, Japan) was used to evaluate the magnetic proper-
ties of the samples (~2 g) at room temperature. The functional 
groups of the samples were identified by using IR Tracer-100 
FTIR (Thermo Nicolet, USA) within the wavelength range of 
400–4000 cm−1. Each sample (~5 mg) was mixed with pow-
der of potassium bromide (KBr) (500 mg) at a ratio of 1:100 
w/w to produce a pellet.
Dynamic Light Scattering (DLS) Analysis 
and Impact of Storage Time on Fe3O4 
Nanofluids
For DLS analysis, Anton Paar instrument was used to 
potentially measure stability of the synthesized samples 
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in the distilled water solution. In order to evaluate the 
effect of storage time on the Fe3O4 NPs dispersions, 
each sample solution (80 mL; 100 μg/mL) was distributed 
into four glass bottles (15 mL each), covered with alumi-
num foil and stored at 4°C.39–41 Zeta potential, hydrody-
namic particle size, and polydispersity index were 
measured immediately post-synthesis (as prepared) and 
subsequently after 1, 2, 3, and 4 weeks of storage. 
Independent experiments were repeated at least three 
times, and the data were expressed as mean ± standard 
deviation for all triplicates within an individual 
experiment.
Magnetic Hyperthermia Studies
To investigate the magnetic hyperthermia efficiency for 
the colloidal magnetic NPs (S0–S4), 1 mg of the sample 
powder was dispersed in 1 mL distilled water (1 mg/mL) 
in accordance with the human body structure, then was 
sonicated for 2 min at a frequency of 1.15 MHz with 
acoustic energy and power of 500 J and 25 W, respec-
tively. The hyperthermia conditions were provided by 
using an induction heating device (Easyheat 3542LI, 4 
kW, Ambrell, Gloucestershire, UK)42 with three varied 
currents of 75, 100, and 125 A, which respectively corre-
sponded to frequencies of 318, 313, and 312 kHz. To 
reduce the temperature variation with the environmental 
condition, the Fe3O4 NPs dispersions were put inside 
a 2 mL glass vial surrounded by a polystyrene box.29,43 
The dispersed S0–S4 samples in a vial vertically were 
placed in the center of a short helical coil with 8-turned 
loops and 2.54, 2.92 and 5.10 cm in inner diameter, outer 
diameter, and length, respectively, and were cooled by 
water circulation to ensure constant temperature and impe-
dance. Temperature changes over time (dT/dt) during the 
hyperthermia experiments were measured with 
a thermocouple connected to a data processing system to 
obtain TH.
The generated magnetic field strengths (H) at different 





Where n, i, and L represent the number of the coil 
turns, applied current (A), and inner coil diameter (m), 
respectively. The calculated values of AMF strength at 75, 
100, and 125 A, were 23.6, 31.5, and 39.37 kA.m−1, 
respectively. Heating efficiency of the Fe3O4 NPs samples 
are quantitatively estimated through  SAR under the exter-









Where Cm is the specific heat capacity of the colloidal 
dispersion, including Fe3O4 and water medium with values 
of 0.65 J.g−1.K−1 and 4.18 J.g−1.K−1, respectively. The mm 
was defined as the total mass of the colloidal dispersion 
comprised the medium and the Fe3O4 NPs sample (iron 
oxide and the extract as a stabilizer) at a concentration of 
1 mg/mL, whereas Cm mm = (Cmedium × mmedium) + (Csample× 
msample). Further, mFe shows the iron mass per unit of the 
Fe3O4 NPs sample (based on the Fe ratio),44 and the dT/dt 
signifies the initial slope of the temperature profile.
Cell Lines and Culture Reagents
HCT116 colon cancer (ATCC CCL-247) and CCD112 
colon normal (ATCC CRL-1541) cell lines were purchased 
from American Type Culture Collection (ATCC) and cul-
tured according to ATCC’s recommendation.6,46 All cell 
lines were cultured in high-glucose Dulbecco’s Modified 
Eagle’s medium (DMEM) (#12800, Thermo Fisher 
Scientific) supplemented with 10% foetal bovine serum 
(FBS) (#10270-106, Thermo Fisher Scientific), and 1% 
penicillin/streptomycin (#15140-122, Thermo Fisher 
Scientific).
In vitro Cytotoxicity Assay
Cytotoxicity assays were conducted to verify the cellular kill-
ing effect of all the samples (S0–S5) by using CellTiter-Glo 2.0 
Luminescent Cell Viability Assay (#G9241, Promega), 
according to the manufacturer’s instruction with a slight 
modification.6,46 Briefly, 5000 HCT116 and CCD112 cells 
per well (100 µL/well) were seeded onto a 96-well plate and 
incubated overnight (12–16 h) at 37°C in a 5% CO2 and 95% 
humidified incubator. After that, 2-fold serially diluted samples 
at concentrations of 0, 15.62, 31.25, 62.53, 125, 250, 500 and 
1000 (100 µL/well) were added into the wells and the plate was 
incubated for 72 h at 37°C in a 5% CO2 humidified 
incubator.16,47 Then, 100 µL of the reagent per well was 
added into the plate and incubated for 1 h at 37°C in 5% CO2 
incubator before the plate was read using a multimode micro-
plate reader (Tecan). The dose–response graph was plotted by 
calculating percent cell viability using the equation below 
(Equation 3):
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% Cell viability ¼
OD of sample well meanð Þ
OD of control well meanð Þ
� 100
(3) 
In addition, the inhibitory concentration, which caused 
50% growth inhibition (IC50) was determined, using an 
online calculator (https://www.aatbio.com/tools/ic50-calcu 
lator) as previously described.16,46
Independent experiments were repeated at least three 
times, and the data were expressed as mean ± standard 
deviation for all triplicates within an individual experi-
ment. Data were analyzed using a Student’s t-test. 
p < 0.05 was considered significant.
Results and Discussion
Reaction
Figure 1 indicates a schematic diagram of the possible che-
mical compounds in the crude extract of G. mangostana fruit 
peel, which served as a stabilizing agent and reacted with 
a mixture solution of Fe3+/Fe2+ ions by using a facile co- 
precipitation method to produce Fe3O4 NPs. The formation 
of the green synthesized Fe3O4 NPs was observed through 
color change of the solution from purple to black. The 
observed response of the synthesized Fe3O4 NPs to an exter-
nal magnet confirmed the magnetic properties of the NPs. 
The physiochemical properties of the green synthesized mag-
netic samples were studied, and the samples were evaluated 
by magnetic hyperthermia analysis and also their cytotoxicity 
assays were analyzed towards colon cancer cell line 
(HCT116) and normal cell line (CCD112).
X-Ray Diffraction (XRD) Analysis
Figure 2 shows the XRD spectra for the synthesized Fe3O4 
NPs. The NPs present a similar pattern and diffraction peaks 
at 2θ = 30.44°, 35.82°, 43.47°, 53.92°, 57.45°, 63.01°, and 
74.69°, which respectively are corresponding to (220), (311), 
(400), (422), (511), (440), and (533) crystal planes of the 
pure cubic spinel crystal structure phase of Fe3O4 based on 
the literature data (JCPDS file no: 00-003-0863).6,16 Debye- 
Scherrer equation (Equation 4) was used to measure the 





Where hkl is the Miller indices of the lattice planes being 
examined, Dhkl is the size of crystallite in direction 
Figure 1 A schematic of the chemical compounds in the crude extract of G. mangostana fruit peel which served as a green stabilizer to synthesize Fe3O4 NPs for magnetic 
hyperthermia study and elimination of the colon cancer cells.
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perpendicular to the lattice planes, K is the crystallite-shape 
factor with a Scherrer constant = 0.9 for an absence informa-
tion of crystallite-shape, λ is a wavelength of X-rays = 
0.154059 nm, βhkl is a full width at half maximum 
(FWHM) of the XRD diffraction peak in radians in 2θ 
scale, and θ is the half diffraction angle of the peak.49 By 
using the equation above, crystallite size of the strongest 
reflection at 35.82° (311) peak for S0, S1, S2, S3, and S4 
samples was 12.84 nm, 12.03 nm, 11.52 nm, 9.34 nm, and 
7.81 nm, respectively. From the XRD patterns of all the 
samples, purity of the crystalline phase was acceptable due 
to low impurity peaks. Therefore, the above results could 
indicate the successful use of the extract as a green stabilizer 
in the synthesis of Fe3O4 NPs (magnetite phase).
Transmission Electron Microscopy (TEM)
Figure 3A–D illustrate TEM image, particle size distribu-
tion, selected area electron diffraction (SAED) pattern, 
and electron diffraction pattern of the S2 sample, respec-
tively. As seen in Figure 3A, most of the particles were 
nearly spherical with potentially good dispersity and 
minor agglomeration. The presence of the agglomeration 
could be due to the van der Waals forces for binding 
particles together and also shear forces that can be 
applied on the nanoscale.50 In addition, the presence of 
the hydroxyl groups in the peel extract could possibly led 
to the agglomeration. A histogram of the NP size distri-
bution was plotted with 220 counts as shown in Figure 
3B. The size distribution was in a range of 6 to 20 nm 
with a mean size of 13.42±1.58 nm, and a standard devia-
tion of 2.74±0.16 nm. Based on the SAED pattern in 
Figure 3C, diffraction rings of the Fe3O4 phase were 
indexed as (311), (220), (400), (422), (511), (440) and 
(533), which was in good agreement with the XRD 
results.6 Figure 3D shows electron diffraction pattern of 
S2, indicating a regular and uniform crystallinity with 
lattice spacing on TEM image around 0.28 nm. 
Therefore, TEM study displayed that the biosynthesized 
Fe3O4 NPs possessed nearly spherical shapes with good 
crystallinity.
Field Emission Scanning Electron 
Microscopy (FESEM) and Energy 
Dispersive X-Ray Spectroscopy (EDS)
Figure 4A and B demonstrate FESEM images and EDS of 
S0–S5, respectively. As seen in the images, the nano-sized 
particles were nearly spherical. In addition, the peel extract 
potentially rolled as a protective agent to cover the surface 
area of the Fe3O4 NPs. Thus, increasing the coating ratio 
around the NPs was in line with the enhancement of the 
extract concentration. However, this coating layer may not 
be seen for S0 as a naked Fe3O4 NPs. Irregular shapes 
were detected because of the agglomeration process pos-
sibly related to the strong inter-particles and Van der Waals 
forces, high surface area to volume ratio, and magnetic 
attraction among the Fe3O4 NPs.6,51 The S5 sample illu-
strated the image of the peel extract with an unorganized 
structure. Figure 4B indicates EDS spectra of the samples. 
The extract powder (S5) presented 64.70 wt.% and 35.80 
wt.% of carbon and oxygen, respectively. These compo-
nents were potentially deposited in the green synthesized 
Fe3O4 NPs. Thus, the samples containing higher concen-
tration of the peel extract possessed higher proportion of 
carbon and oxygen. In this manner, the ratio of carbon was 
higher in S4 than S1, showing the successful use of the 
extract as a stabilizer in the green synthesis of Fe3O4 NPs. 
Therefore, EDS spectrum of the Fe3O4 samples exhibited 
Figure 2 XRD spectra of the synthesized Fe3O4 NPs (S0–S4).
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good purity of the compounds, owing to the presence of 
iron, carbon, and oxygen elements.
Vibrating-Sample Magnetometer (VSM)
The VSM study of the synthesized Fe3O4 samples is 
illustrated in Figure 5A and B. The saturation magnetiza-
tion of S0–S4 was found to be 73.15, 69.42, 64.35, 59.50, 
and 49.80 emu/g, respectively, at room temperature. The 
samples with the higher extract ratio showed lower mag-
netic properties, indicating the contribution of the extract 
stabilizer for the biosynthesis of Fe3O4 NPs. When the 
magnetic field was removed, an increase in the applied 
field rose the magnetic moment/mass. Hysteresis loops 
occurred when the external magnetic field was applied to 
the NPs,52 and magnetization decreased from a plateau 
value to zero. The increase of the extract ratio decreased 
and increased the saturation magnetization and the coer-
civity of the samples, respectively. Of this, among the 
Fe3O4 samples, S0 as a bare magnetic NPs indicated the 
lowest coercivity of 10.80 Oe and the highest saturation 
magnetization of 73.15 emu/g. However, S4 containing 
the highest extract ratio (10 wt.%) showed the highest 
coercivity (87.21 Oe) and the lowest saturation magneti-
zation (49.80 emu/g). This is due to the non-magnetic 
nature of the extract as coated the magnetic NPs. It can 
be understood from the VSM results, the green synthe-
sized Fe3O4 NPs could be conveyed by an external mag-
netic field and potentially directed to a specific target 
inside the body for biomedical applications, although 
future studies would need to focus on.
Fourier-Transform Infrared Spectroscopy 
(FTIR)
Figure 6 shows FTIR spectra of S0–S5. The samples with 
higher concentration of the extract stabilizer displayed 
transmittance peaks closer to the crude extract alone in 
a similar wavenumber range. The intensity of C=O stretch-
ing vibration and C-O stretch increased due to the pre-
sence of the carbonyl group in the anthocyanin structure 
and alcohol group, respectively.53 In the green synthesized 
Fe3O4 NPs samples (S1-S4), a broad band between 
1621 cm−1 and 1649 cm−1 could be due to C=O stretching 
Figure 3 (A) TEM image, (B) histogram of the Fe3O4 NPs distribution, (C) SAED pattern, and (D) electron diffraction pattern of the synthesized Fe3O4 NPs of S2.
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vibration.6 Furthermore, the peaks in a range from 
3442 cm−1 to 3596 cm−1 were assigned to the hydroxyl 
group, representing the O-H stretching vibration, which 
was higher for the Fe3O4 NPs samples with the higher 
extract ratio. The functional groups of O-H, C=O, and 
C-O could possibly indicate the presence of gartanin 
Figure 4 (A) FESEM image (scale bar = 200 nm ____) and (B) EDS spectra of the synthesized Fe3O4 NPs (S0–S4) and the crude extract of G. mangostana fruit peel (S5).
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compound in the samples. Gartanin is a chemical com-
pound in xanthone isolated from G. mangostana fruit 
peel.54 In all spectra of the synthesized Fe3O4 NPs, 
peaks appeared at a range from 636 cm−1 to 721 cm−1, 
showing characteristic of metal-oxygen band, which was 
the Fe-O stretching vibration of Fe3O4 NPs.55 These 
Figure 5 (A) Saturation magnetization and (B) coercivity of the synthesized Fe3O4 NPs (S0–S4).
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stretching vibration bands could be linked to the metal in 
the tetrahedral and octahedral site.56 Based on FTIR ana-
lysis of Fe3O4 NPs stabilized with Lagenaria siceraria 
extract, the stretching vibration at 3354 cm−1, 
1701.55 cm−1, and 624 cm−1 represented the presence of 
O-H bond stretching, C=O stretching, and Fe-O stretching, 
respectively.6 From the FTIR spectrum of S5, a peak at 
3598 cm−1 was assigned to the presence of O-H stretch 
and H-bonding and a peak at 2911 cm−1 indicated the 
C-H stretching vibration band.53 The characteristic of the 
carbonyl group is the C=O stretching vibration at 
1652 cm−1, whereas, the presence of the aromatic group 
was indicated by the band at 1460 cm−1. The peaks 
between 1300 cm−1 to 1000 cm−1 were attributed to the 
functional group of C-O as it potentially related to the 
alcohols, ethers, ester, carboxylic acids, and amides in 
the crude extract of G. mangostana fruit peel.53 
Compared to other green synthesized Fe3O4 NPs, the 
extract showed the highest impact on the S4 sample, 
which contained the highest extract ratio (10 wt.%). In 
this manner, the O-H stretching peak of the extract’s 
spectrum shifted from 3598 cm−1 to 3470 cm−1 after the 
biosynthesis of Fe3O4 NPs. Meanwhile, the peak for the 
C=O and C-O stretching vibration of S5, respectively, 
shifted from 1652 cm−1 to 1628 cm−1 and from 
1015 cm−1 to 1031 cm−1 after capping with Fe3O4 NPs 
in the S4 sample. Thus, the FTIR results could indicate 
that the extract successfully served as both stabilizing and 
capping agents during the green synthesis process of the 
Fe3O4 NPs.
Dynamic Light Scattering (DLS) Analysis 
and Impact of Storage Time on Fe3O4 
Nanofluids
Table 1 depicts DLS results with values of zeta potential, 
hydrodynamic size, and polydispersity index of the sam-
ples, respectively. Adding the extract stabilizer increased 
the zeta potential value and also the hydrodynamic size. 
Among the synthesized magnetite samples, S0 as a bare 
Fe3O4 NPs sample had the lowest hydrodynamic size and 
the zeta potential value of 95.93±2.2 nm and −20.72±1.7 
mV, respectively. Although, S4 with the highest stabilizer 
concentration (10 wt.%) showed the highest hydrodynamic 
size and zeta potential value of 176.15±1.46 nm and 
−34.92±1.26 mV, respectively. This may exhibit that coat-
ing the NPs with the plant extract provided a repulsive 
force between the NPs.57 Compared to the TEM size, the 
DLS size was larger for S2. This can be explained that 
DLS indicates the combination of particle size and sur-
rounding diffuse layer of the particle; however, TEM 
analysis is attributed to the particle size alone. In the 
aqueous media, the presence of the particle−particle inter-
actions affected hydrophobic attraction energy between 
Fe3O4 NPs to attract each other, albeit, hydrophilic extract 
potentially governed hydrophilicity of the NPs to improve 
their thermodynamic stabilities.58 The extract may also act 
as a tailoring agent to improve the surface features of the 
synthesized Fe3O4 NPs in the aqueous media. As value of 
zeta potential increased, polydispersity index decreased, 
showing that zeta potential was inversely attributed to 
polydispersity index. All the samples displayed the poly-
dispersity index values below 0.7. This indicates that the 
extract of G. mangostana fruit peel as a new stabilizer 
potentially caused the nucleation of the Fe3O4 with 
a narrow dispersity.6 In a different study, Sathishkumar 
et al57 synthesized Fe3O4 NPs using a stabilizer of 
Couroupita guianensis Aubl. fruit extract, that the zeta 
potential of the fabricated NPs was found to be −26 mV.
Figure 6 FTIR spectra of the synthesized Fe3O4 NPs (S0–S4) and the crude extract 
of G. mangostana (S5).
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As provided in Table1, the zeta potential values of 
S0–S4 after the storage of 1, 2, 3, and 4 weeks were 
slightly and gradually decreased. This can indicate the 
low particle agglomeration and aggregation are in the 
line with time, which is similar to different reports.41,59 
The zeta potential values exhibited that the Fe3O4 NPs 
suspensions with the higher extract ratio could present 
better colloidal stability than those NPs with the lower 
extract ratio after 4 weeks of storage. Particle size of 
the magnetic nanofluid samples at different storage 
time was obtained from DLS measurement (Table 1). 
Figure 7A and B show the hydrodynamic size distribu-
tions of S0–S4 as prepared and after 4 weeks of sto-
rage, respectively. An increase in the average particle 
size after the prolonged storage could be related to 
a minor agglomeration in the Fe3O4 NPs. Albeit, 
there was no major agglomeration visually noticed on 
the sample suspension even after 4 weeks of storage. In 
addition, the polydispersity index values were almost 
unchanged with the values below 0.7 even after 4 
weeks of storage. Therefore, the Fe3O4 NPs suspen-
sions displayed good stability during 4 weeks of 
storage.
Magnetic Hyperthermia Study
The hyperthermia performance of the Fe3O4 NPs samples 
was assessed through measuring their temperature rise 
under the exposure of different AMF strengths to deter-
mine the minimal AMF strength. Further, the TH main-
tained within the secure hyperthermia range in order to 
prevent unpredictable disorders and subsequently perform 
a successful MHT. The thermal profiles of the nanofluid 
samples containing 1 mg/mL of Fe3O4 NPs under the 
exposure of varied AMF strengths of 23.60, 31.50, and 
39.37 kA.m−1 over 3600 sec are illustrated in Figure 8. All 
the graphs illustrate almost a similar thermal behavior 
throughout the treatment time under different AMF expo-
sure. Clearly shown that the temperature increased signifi-
cantly until 360 sec (Phase 1), followed by a moderate 
temperature rise until heating intervals of approximately 
1800 sec (phase 2). Then, the temperature raised negligi-
bly in the aqueous medium (phase 3). The highest effect of 
the AMF strength was observed in phase 1, where the 
slope of the temperature rise (dT/dt) at this stage which 
was significantly higher than the other phases. Hence, the 
slope of the phase 1 for all of the thermal profiles was 
considered for the SAR value measurements. The SAR 




After 1 Week of 
Storage
After 2 Weeks of 
Storage
After 3 Weeks of 
Storage
After 4 Weeks of 
Storage
Sample Zeta potential (mV)
S0 −20.72±1.7 −16.96±1.1 −15.26±2.2 −14.58±1.6 −12.00±1.6
S1 −25.61±1.8 −24.32±0.5 −23.77±1.3 −22.24±1.4 −20.22±1.9
S2 −28.64±1.3 −27.44±1.0 −26.92±1.2 −25.14±0.2 −22.71±1.5
S3 −29.58±1.1 −27.87±1.4 −25.45±1.8 −25.17±1.3 −24.36±1.4
S4 −34.92±1.2 −34.25±0.9 −33.14±1.1 −31.83±2.2 −30.15±2.7
S5 −15.66±1.2 −11.54±2.0 −8.23±2.3 −7.65±1.5 −6.82±0.5
Hydrodynamic particle size (nm)
S0 95.93±2.2 97.23±1.6 109.98±1.3 125.00±1.2 134.00±2.6
S1 107.90±0.2 110.09±1.3 115.27±0.5 121.20±1.1 128.20±2.1
S2 120.34±1.7 125.47±1.0 127.54±1.2 130.90±1.0 134.84±1.5
S3 145.82±1.0 150.63±1.4 150.81±1.8 158.28±1.4 165.61±2.1
S4 176.15±1.4 180.35±0.9 184.00±1.1 190.44±1.8 198.27±2.0
Polydispersity index
S0 0.31±0.03 0.40±0.06 0.42±0.03 0.45±0.02 0.50±0.06
S1 0.29±0.02 0.35±0.04 0.38±0.05 0.40±0.01 0.41±0.07
S2 0.27±0.02 0.31±0.06 0.33±0.02 0.35±0.04 0.39±0.09
S3 0.25±0.04 0.29±0.09 0.33±0.06 0.34±0.04 0.35±0.02
S4 0.23±0.01 0.25±0.03 0.28±0.04 0.30±0.08 0.32±0.04
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values of the nanofluid samples exposed to different AMF 
strengths are provided in Table 2. The SAR values 
increased considerably with increasing AMF strengths 
from 23.60 kA.m−1 to 39.37 kA.m−1 due to the heating 
loss mechanisms,60 which is also in line with previous 
research reports such as bare superparamagnetic Fe3O444 
Figure 7 Hydrodynamic size distributions of the nanofluid samples containing Fe3O4 NPs (A) as-synthesized and (B) after four weeks of storage.
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and polycaprolactone-coated Fe3O445 and γ-Fe2O3.42 The 
SAR values reduced remarkably with increasing the 
extract concentrations from 0 to 10 wt.%, which might 
be ascribed to the non-magnetic nature, which acted as 
a heating barrier for the Fe3O4 NPs. Thereby, the highest 
and the lowest SAR values were respectively obtained for 
S0 and S4 at each AMF strength. Nevertheless, S1 with 
the lowest extract concentration could render significant 
SAR value as compared to other extracted counterparts 
with values of 165.74±0.5 W.g−1, 212.06±0.4 W.g−1, and 
246.86±0.2 W.g−1 at 23.6 kA.m−1, 31.5 kA.m−1, and 39.37 
kA.m−1, respectively.
Although the S0 sample could show the highest SAR 
values over the range of AMF strengths, this sample was 
incapable of maintaining TH at the secure hyperthermia 
range (42–47°C) even at the minimal applied AMF 
strength of 23.6 kA.m−1. However, the extract could 
potentially control the medium temperature of the nano-
fluid under the hyperthermia condition to produce suffi-
cient thermal energy within the secure hyperthermia 
range.56 The data provided in Table 2 clearly implies that 
the S4 sample with the highest extract concentration 
(10 wt.%) could retain a medium temperature rise within 
the secure hyperthermia range which is appropriate for 
Figure 8 The temperature profiles of the nanofluid samples containing the synthesized Fe3O4 NPs of S0–S4, which were obtained after exposure to the varied AMF 
strengths of 23.60 kA.m−1, 31.50 kA.m−1, and 39.37 kA.m−1.
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prospective hyperthermia treatment. The S4 solution indi-
cated temperature rise (with the SAR values) of 42±0.2°C 
(98.74±0.6 W.g−1), 43±0.2°C (130.48±0.3 W.g−1) and 
44±0.4°C (179.85±0.1 W.g−1) at AMF strengths of 
23.6 kA.m−1, 31.5 kA.m−1, and 39.37 kA.m−1, respec-
tively. The extract of G. mangostana peel as a novel 
stabilizer could trigger a positive effect on Fe3O4 NPs 
preparation to perform a successful MHT. Therefore, 
according to the obtained magnetic hyperthermia results 
from Table 2, the synthesized Fe3O4 NPs stabilized with 
the extract could be considered as a promising candidate 
for hyperthermia therapy of cancer. 
In vitro Cytotoxicity Assay
Figure 9A and B demonstrate the cytotoxic effects of S0– 
S5 against colon cancer (HCT116) and normal cell lines 
(CCD112) after 72 h of treatment, respectively. Dose- 
dependent killing effect was seen in all the tested samples 
in both cell lines. Table 3 indicates the IC50 of S0–S5 
against the colon cancer and normal cell lines. The crude 
extract of G. mangostana fruit peel showed higher antic-
ancer activity compared to the extracts of different plants 
such as Punica granatum fruit peel,6 Juglans regia green 
husk,16 and seaweed (Kappaphycus alvarezii).61 This 
could be due to the presence of xanthone and α-mangostin 
in the crude extract of G. mangostana peel.62 Among all 
the magnetic samples, S4 with the highest extract concen-
tration (10 wt.%) showed the highest killing effect against 
the cancer cells with the lowest IC50 (99.8 µg/mL). The 
IC50 of S4 in the normal cells was found to be 140.80 µg/ 
mL, which was slightly higher than that of the cancer cells. 
Figure 10 summarizes the toxicity of S4 on HCT116 
cancer and CCD112 normal cell lines. At 125 µg/mL and 
250 µg/mL, S4 killed 52±0.54% and 63±1.68% of the 
cancer cells, respectively. At 500 µg/mL and 1000 µg/ 
mL, S4 caused respectively, 72±1.15% and 80±0.61% kill-
ing effects against the cancer cells; however, it displayed 
63±2.17% and 68±1.05% elimination of the normal cells, 
respectively. The anticancer activity of the magnetic sam-
ples possibly could be due to release of iron ions from the 
Fe3O4 NPs following its breakdown and the subsequent Fe 
reutilization process by cells for Fe metabolism, which 
could be one of the cancer cell killing mechanisms.63 It 
is worth mentioning that the extract as a stabilizer and 
capping agent possibly tailored assemblies of Fe3O4 NPs 
with a temperature-responsive structure, and self-heating 
capacity to destroy the cancer cells. The nucleation of the 
NPs in the presence of the extract was translated into an 
efficient bonding between the phenolic compounds of the 
extract into/onto the NPs to strongly avoid deep oxidation, 
possibly suitable for various biomedical applications.13,15 
As previously reported,64 normal cells could decrease their 
heat-sensitivity five or six times than that of the growing 
situation at the conflux, but the cancer cells were unable. 
In this manner, cancer cells might indicate higher tempera-
ture (above 37°C) compared to normal cells (below 37°C). 
Table 2 The Achieved Hyperthermia Properties of the Nanofluid Samples Containing Fe3O4 NPs and Varied Extract Concentrations 
Exposed to Different AMF Strengths Over 360 Sec
Sample Frequency (kHz) Current (A) AMF Strength (kA.m−1) TH (°C) SAR (W.g−1)
S0 318 75 23.6 49±0.2 188.67±0.5
313 100 31.5 51±0.2 218.64±0.3
312 125 39.37 54±0.6 260.96±0.4
S1 318 75 23.6 46±0.3 165.74±0.5
313 100 31.5 49±0.4 212.06±0.4
312 125 39.37 52±0.3 246.86±0.2
S2 318 75 23.6 45±0.4 144.59±0.5
313 100 31.5 47±0.3 195.72±0.2
312 125 39.37 49±0.6 239.80±0.4
S3 318 75 23.6 43±0.5 128.72±0.3
313 100 31.5 45±0.3 178.79±0.2
312 125 39.37 48±0.4 225.70±0.3
S4 318 75 23.6 42±0.2 98.74±0.6
313 100 31.5 43±0.2 130.48±0.3
312 125 39.37 44±0.4 179.85±0.1
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This slightly increased temperature of the cancer cells 
might trigger higher release of the phenolic compounds 
against the cancer cells. To our best understanding from 
these in vitro results, certain concentrations of the 
biosynthesized Fe3O4 NPs effectively eliminated the 
colon cancer cells; however, further improvements such 
as surface modifications and/or polymer coating on the 
NPs may decrease the toxicity of the G. mangostana/ 
Fe3O4 samples on the normal cells.
Conclusion
In this work, the green synthesis of Fe3O4 NPs was con-
ducted by using a novel stabilizer of the crude extract of 
G. mangostana fruit peel at various concentrations (1, 2, 5, 
and 10 wt.%). TEM analysis of the magnetic sample con-
taining 2 wt.% of the extract showed the spherical NPs 
with an average size of 13.42±1.58 nm and its SAED 
pattern was related to the Fe3O4 magnetite phase, which 
was in well agreement with the XRD data. Based on the 
Figure 9 Relative viability of (A) CCD112 colon normal cell line and (B) HCT116 colon cancer cell line treated with the synthesized Fe3O4 NPs (S0–S4) and the crude 
extract of G. mangostana (S5). Data are expressed as mean ± standard deviation for triplicates within an individual experiment. Statistical significance was performed using 
a Student’s t-test (*p < 0.05).
Table 3 Inhibitory Concentration (IC50) of S0–S5 on HCT116 
and CCD112 Cell Lines
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FESEM images, the green synthesized NPs were sur-
rounded by the extract. The saturation magnetization 
values of the samples with the lowest and highest extract 
concentration were 49.80 emu/g and 69.42 emu/g, respec-
tively. The FTIR data indicated that the green synthesized 
Fe3O4 NPs contained the spectroscopy peaks related to the 
iron and the extract with xanthone, carboxylic, alcohol, 
and aromatic groups. The Fe3O4 nanofluids containing the 
highest ratio of the extract stabilizer indicated an improved 
particle charge of −34.92±1.26 mV and hydrodynamic size 
of 176.15±1.46 nm. Furthermore, the DLS analysis exhib-
ited that the Fe3O4 nanofluids showed the colloidal stabi-
lity even after 4 weeks of storage. The Fe3O4 nanofluids 
can be potentially used in hyperthermia therapy, since they 
mostly caused the TH increase at the secure hyperthermia 
range (42–47°C) and the acceptable SAR values with the 
thermosensitive performances under exposure to AMF. 
Cytotoxicity assays of the samples were evaluated against 
CCD112 normal and HCT116 colon cancer cells. 
Particularly, the Fe3O4 NPs containing 10 wt.% of the 
extract showed a lower IC50 value (99.80 µg/mL) in 
HCT116 than in CCD112 (140.80 µg/mL). Consequently, 
this study indicated that the extract of G. mangostana fruit 
peel is a low-cost stabilizing and capping agent to improve 
the colloidal stability and physiochemical properties of the 
Fe3O4 NPs for potential hyperthermia therapy and antic-
ancer treatments. Further investigations can lead to 
enhance the selectivity of the samples towards the cancer 
cells with the minimal toxicity on the normal cells. It can 
be considered to load an anticancer drug onto the green 
synthesized Fe3O4 NPs for the future study.
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